Live
- ‘Vaaradhi’ set for Dec 27 release, pre-release event held
- ‘Daaku Maharaaj’ team expresses confidence on film; set for Jan 12 release
- ‘It’s Okay Guru’ drops soulful song with actor Siddharth vocals
- Kichcha Sudeep’s ‘Max’ trailer looks powerful
- Bengal school job case: Court rejects accused's plea to return to US by Jan 2
- ‘Drinker Sai’ appeals to both younger and family audiences: Producer Basavaraju Laharidhar
- Kerala BJP’s ‘love’ towards Christians is fake: Ex party leader
- Google Gemini Now Features PDF Screen Awareness in the Files App
- Anupama graces Vogue India’s January-February cover
- Captivating poster from ‘Shambhala’ unveiled
US CDC recommends Novavax's Covid vaccine for adults
The US Centers for Disease Control and Prevention (CDC) has endorsed recommendation that Novavax's Covid-19 vaccine be used as another primary series option for adults ages 18 years and older.
The US Centers for Disease Control and Prevention (CDC) has endorsed recommendation that Novavax's Covid-19 vaccine be used as another primary series option for adults ages 18 years and older.
The recommendation came on Tuesday following a meeting of the CDC Advisory Committee on Immunization Practices, Xinhua news agency reported.
The Novavax vaccine will be available as two-dose primary series for adults, three weeks apart.
It is the fourth Covid-19 vaccine available in the US, and it uses a different type of vaccine technology than the other three approved vaccines.
"Novavax's Covid-19 vaccine, which will be available in the coming weeks, is an important tool in the pandemic and provides a more familiar type of Covid-19 vaccine technology for adults," said the CDC in a statement.
Last week, the US Food and Drug Administration issued an emergency use authorisation for the Novavax Covid-19 vaccine in individuals 18 years of age and older.
